<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ratnaparkhe M</submitter><funding>Fritz Thyssen Stiftung</funding><funding>NCI NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>Fritz Thyssen Stiftung (Fritz Thyssen Foundation)</funding><pagination>4760</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6232171</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(1)</volume><pubmed_abstract>Chromothripsis and chromoanasynthesis are catastrophic events leading to clustered genomic rearrangements. Whole-genome sequencing revealed frequent complex genomic rearrangements (n = 16/26) in brain tumors developing in mice deficient for factors involved in homologous-recombination-repair or non-homologous-end-joining. Catastrophic events were tightly linked to Myc/Mycn amplification, with increased DNA damage and inefficient apoptotic response already observable at early postnatal stages. Inhibition of repair processes and comparison of the mouse tumors with human medulloblastomas (n = 68) and glioblastomas (n = 32) identified chromothripsis as associated with MYC/MYCN gains and with DNA repair deficiencies, pointing towards therapeutic opportunities to target DNA repair defects in tum</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumors.</pubmed_title><pmcid>PMC6232171</pmcid><funding_grant_id>P30 CA021765</funding_grant_id><funding_grant_id>P01 CA096832</funding_grant_id><funding_grant_id>Az.10.17.2.030MN</funding_grant_id><funding_grant_id>R01 NS037956</funding_grant_id><pubmed_authors>Haag D</pubmed_authors><pubmed_authors>Kolb T</pubmed_authors><pubmed_authors>Kool M</pubmed_authors><pubmed_authors>Simovic M</pubmed_authors><pubmed_authors>Mlynarski W</pubmed_authors><pubmed_authors>Zapatka M</pubmed_authors><pubmed_authors>Jones DTW</pubmed_authors><pubmed_authors>Downing SM</pubmed_authors><pubmed_authors>Pfister SM</pubmed_authors><pubmed_authors>Wei PC</pubmed_authors><pubmed_authors>Ratnaparkhe M</pubmed_authors><pubmed_authors>Korshunov A</pubmed_authors><pubmed_authors>Kumar R</pubmed_authors><pubmed_authors>McKinnon PJ</pubmed_authors><pubmed_authors>Paul Y</pubmed_authors><pubmed_authors>Lichter P</pubmed_authors><pubmed_authors>Northcott P</pubmed_authors><pubmed_authors>Wong JKL</pubmed_authors><pubmed_authors>Jauch A</pubmed_authors><pubmed_authors>Ernst A</pubmed_authors><pubmed_authors>Alt FW</pubmed_authors><pubmed_authors>Hlevnjak M</pubmed_authors><pubmed_authors>Pastorczak A</pubmed_authors><pubmed_authors>Devens F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumors.</name><description>Chromothripsis and chromoanasynthesis are catastrophic events leading to clustered genomic rearrangements. Whole-genome sequencing revealed frequent complex genomic rearrangements (n = 16/26) in brain tumors developing in mice deficient for factors involved in homologous-recombination-repair or non-homologous-end-joining. Catastrophic events were tightly linked to Myc/Mycn amplification, with increased DNA damage and inefficient apoptotic response already observable at early postnatal stages. Inhibition of repair processes and comparison of the mouse tumors with human medulloblastomas (n = 68) and glioblastomas (n = 32) identified chromothripsis as associated with MYC/MYCN gains and with DNA repair deficiencies, pointing towards therapeutic opportunities to target DNA repair defects in tum</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Nov</publication><modification>2026-07-15T19:04:19.157Z</modification><creation>2026-07-09T03:10:24.496Z</creation></dates><accession>S-EPMC6232171</accession><cross_references><pubmed>30420702</pubmed><doi>10.1038/s41467-018-06925-4</doi></cross_references></HashMap>